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XIV International Congress of Nephrology
The XIVth International Congress of Nephrology will be held in
Sydney, Australia on May 25—29, 1997. The ISN will grant 120
travel scholarships at a cost of $1000 each. These scholarships are
meant for physicians and scientists, 35 years of age or younger,
who submit an abstract as first author. First priority will be given
to past fellows of the ISN Fellowship Program. There is also some
type of priority based on membership and country of origin
(developing versus developed countries). Application forms for
these grants can be obtained from: Dr. Jan Weening, Department
of Pathology, AMC, Meibergdreef 9, 1105 AZ Amsterdam, The
Netherlands. Telephone: 31 20 566 4100; FAX: 31 20 696 0389.
For further Congress information and abstract forms, contact The
XIVth International Congress of Nephrology, ICMS Australia Pty
Limited, GPO Box 2609, Sydney NSW 2001, Australia. Tele-
phone: (612) 241-1478; FAX (612) 251-3552.
XIV International Congress of Nephrology, Sydney, 1997
program update
The XIVth International Congress of Nephrology will be held
at the Sydney Convention Centre from May 25—29, 1997. The
following information includes highlights and more recently
planned features of the meeting and is additional to that provided
in the official registration document (posted July 1996). If you
have not received this brochure, it is available from the Congress
organizers (see address below).
Prior to the main meeting, there will be an International
Scholarship Course for trainee nephrologists from developing
countries within the Asian Pacific region. This will be held on May
22nd and 23rd and will address both clinical and basic aspects of
nephrology. The major sponsor is Takeda. Commencing on
Saturday May 24th there will be a series of Symposia dealing with
specific aspects of renal therapy. These Symposia, each of 3 to 4
hours duration, have been financed by nine of our major sponsors
and their details are listed below:
Saturday May 24th
Afternoon: "Nephroprotective properties of ACE inhibitors in
diabetic and non-diabetic proteinuric nephropathy"
(Hoechst Marion Roussel).
Sunday May 25th
Morning: "Advances in prescription management to optimize
dialysis outcomes" (Baxter).
"Future challenges in optimizing the use of
r-HuEPO in chronic renal failure" (Janssen-Cilag).
Afternoon: "Angiotensin II antagonism—An emeiging option
for patients with progressive renal disease" (Merck
& Co.).
"Hypertension and progressive renal disease."
(Pfizer).
Monday May 26th
Afternoon: "Calcium antagonists in kidney protection—Time for
a reappraisal" (Bayer).
"Innovations in dialysis technology and treatment"
(Fresenius).
Tuesday May 27th
Afternoon: "Optimizing outcomes in transplantation—New
products and technologies" (Sandoz).
"Alternative approaches to maximizing renal
transplantation survival—Lipid lowering and
interruption of the renin-angiotensin system"
(Bristol-Myers Squibb).
Main Scientific Program
Seven major themes will run concurrently on all four days of the
meeting, and within each theme there will be a fairly even balance
of basic and clinical sessions. Every effort has been made to match
room size and the anticipated audience. There will be 8 to 10
sessions within each theme, and two or three of these will consist
of a State-of-the-Art lecture and two shorter related talks. These
sessions have been staggered so that there will be one or two at all
times through the meeting. State-of-the-Art sessions will be
recorded and a CD-ROM made available soon after the meeting.
The remaining sessions will be Symposia (3 to 4 speakers) and will
provide ample time for audience participation.
Apart from the main themes, there will also be sessions on
refiux nephropathy, bone disease, registries, international trials
and an ISN Video Legacy. The Congress will also bring together
National Kidney Foundations to discuss areas of interest to
delegates who work with, or serve on committees of non-govern-
ment, not-for-profit organizations involved in fund raising for
medical research, education and public awareness programs.
Three 1½ hour sessions will be held to consider fund raising and
education (including target groups, resources, media and patient
support) and will end with a discussion of ideas for an information
exchange.
Plenary Sessions will be held each day prior to lunch. They are
listed in the table and will also be recorded onto CD-ROM. The
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Richards and Hamburger Awards will also take place during the
Thursday pre-lunch session.
Monday Sergio Romagagni The Thl/Th2 paradigm in disease
Grant Sutherland Kidney and the human genome
project
Tuesday Victor Dzau
Daniel Bichet
Genetic engineering and
molecular therapy for kidney
disease
Claude Amid lecture:
Nephrogenic diabetes insipidus
Wednesday Rashad Barsoum
Somei Kojima
Graeme Brown
Tropical parasitic nephropathies
Molecular biology of malaria
Clinical aspects of malaria
Thursday Masashi Yanagisawa Donald Seldin Lecture:
Endothelin
Latest Advances. A small number of abstracts have been
selected for oral presentation. There will be a single "Latest
Advances" session, comprising approximately six free communi-
cations, within each theme. These sessions will be staggered
throughout the meeting.
Posters. More than 2000 abstracts have been accepted for
poster presentation. They have been received from 67 countries
and will be displayed for a single day with authors present for
discussion during a two-hour lunch break. Posters will be orga-
riized according to the seven themes of the meeting and, within
each theme, will be organized according to topic, and will
complement the day's thematic sessions. Two chairpersons will be
selected to lead the discussion on a selected number of posters in
a way that will be stimulating to authors and audience alike.
Perspectives and Advances in Clinical Nephrology (PA CN)
The continuing medical education program has been designed
to assist registrants to place recent advances in a clinical context
and to allow maximum opportunity for participation. It has been
accredited by Vanderbilt University.
There will be three components. Each day, from Monday to
Thursday, will begin with three parallel, 90-minute breakfast
sessions. Two or three internationally renowned authorities will
discuss relevant "hot" topics. In one room, key pads will be used
to enhance audience involvement. These sessions will emphasize
clinical relevance of recent developments as well as present
consensus in controversial areas. During the afternoons there will
be smaller group interactive sessions in four rooms holding up to
200 delegates. In these sessions selected authoritative teachers
will introduce the topics and interact with the audience answering
questions and stimulating discussion. A syllabus will be available
for all delegates and will contain resumes of all PACN presenta-
tions. A CD-ROM of the breakfast sessions will be available soon
after the meeting,
The third component is the role of the computer in ncphrologi-
cal practice. This will he covered in a breakfast session on
Nephrology in Cyberspace, and a designated room will allow
access to the latest in computer technology for the clinician.
Satellite Meetings
Six Satellite meetings will be held after the main Congress. We
wish to highlight some details that were not available at the time
of printing of the registration document:
1. ANCA (May 30th—June 1st, Melbourne). There will be sessions on
laboratory detection of ANCA, novel target antigens, mechanisms of
disease and treatment. Invited speakers include R. Falk, A. Wiik, C.
Jennette, C. Savage, D. Davies.
2. Hypertension associated with diabetes ,nellitus (May 30th—June 1st,
Maroochydore, Queensland). Syndrome X, pathogenesis of nephropathy
and treatment of hypertension in diabetes. There will be conjoint
sessions with Satellite 6 (below).
3. History of Dialysis (May 30th, Sydney). A faculty of pioneers of dialysis
therapy will review early contributions to dialysis technology. The
development of concepts of uremia, membranes, dialyzers, ethics and
registries will be discussed.
4. Renal Disease in indigenous Populations (May 31st—June 1st, Ayers
Rock). The role of screening, treatment and prevention, cost benefits,
etc., will be discussed. There will be a demonstration of renal telemedi-
cine.
5. Acute Renal Failure (June lst—3rd, Cairns). There will be sessions on
diagnosis and imaging, new anti-rejection agents, signalling and cell
injury, hypoxic injury, nephrotoxins, new strategies in dialysis and
clinical trials in ARF.
6. Progression of Renal Disease—What We Have Learned From Clinical
Trials (June lst—3rd, Coolum, Queensland), There will be keynote
lectures, a plenary session and six other sessions devoted to clinical
trials in IDDM, NIDDM and non-diabetic renal disease. Methodolog-
ical issues in clinical trials will also be discussed.
Further information about all aspects of the Congress, includ-
ing registration requirements, is available on the Internet: www.
nephrology.edu.au/—congress; or can be obtained from the Con-
gress organizers: ICMS Australasia Pty. Limited, P.O. Box 2609,
Sydney. Facsimile No: 61 2 9251 3552, Phone: 61 2 9241 1478.
Progression of Renal Disease: Clinical Patterns, Therapeutic Op-
tions and What We Have Learned from Clinical Trials, a Satellite
Symposium of the XIVth international Congress of Nephrology,
will be held May 31—June 3, 1997 in Coolum, Australia. The
program will discuss insights gained from clinical trials, evaluating
risk factors, outcomes, and therapeutic interventions in diabetic
and nondiabetic progressive renal disease. Emphasis will be on
variability in disease progression and our understanding of this in
light of the pathophysiology of progressive renal disease. In
addition, there will be discussions aimed at developing a consen-
sus pertaining to appropriate endpoints for future clinical trials
and future research directions. A maximum of 50 abstracts will be
accepted for poster presentation. Deadline for submission of
abstracts if March 1, 1997. The registration fee for physicians is
$150, with attendance limited to 200 participants. The registration
deadline is March 1, 1997. For additional information contact the
office of Dr. William F. Keane, attention Deanna Gunderson,
1-lennepin County Medical Center, 701 Park Avenue South,
Minneapolis, Minnesota 55415, USA. Telephone: 612-437-4322;
FAX: 612-347-4321; or ICMS Australasia PTY LTD, GPO Box
2609, Sydney 2001, Australia. Telephone: 61 2 9241 1478; FAX:
61 2 9251 3552.
Report to the ISN Commission for Global Advancement
of Nephrology
Eberhard Ritz, on behalf of the
Central and Eastern Europe Subcommittee
As discussed at the ISN Congress in Madrid in 1995, the
subcommittee for Central and Eastern Europe has approached
